Project Details
Description
A Long-term, Open-label Study to Evaluate the Safety, Pharmacodynamics, and Efficacy of Migalastat in Subjects > 12 Years of Age with Fabry Disease and Amenable GLA Variants
| Status | Active |
|---|---|
| Effective start/end date | 1/6/21 → 1/5/27 |
Funding
- AMICUS THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.